Brachytherapy is a Promising Treatment for Prostate Cancer
2017; Volume: 10; Issue: 1 Linguagem: Inglês
10.18499/2070-478x-2017-10-1-79-85
ISSN2409-143X
AutoresDmitry Yurievich Kamenev, И П Мошуров, Б Б Кравец, Н В Коротких,
Tópico(s)Prostate Cancer Treatment and Research
ResumoAbstract – prostate Cancer is one of the most common cancers among men. Incidence is second only to tumors of the broncho- pulmonary system. In recent years significantly increased the interest in contact radiation methods of treatment of this disease (brachytherapy). In the treatment of prostate cancer there is experience of application of different source of dose-rate used sources of low dose (isotopes of iodine (125I), palladium (103Pd) and cesium (131Cs) and sources used for high dose rate (iridium Ir192 or cobalt 60 Co). In Russia the greatest popularity is the use of isotope Ir192 andI125 for brachytherapy. Given indentichnost the indications for treatment, equivalent figures cancerspecifically and relapse-free survival, the question of the choice of treatment is very important. A brief review of the literature on the use of brachytherapy for prostate cancer sources of different dose. Presents comparative characteristics of treatment results, complications, early and late toxic reactions when used brachytherapy isotopes different dose.
Referência(s)